Observational studyRheumatology international2024
Belimumab corticosteroid-sparing treatment in systemic lupus erythematosus: a real-life observational study (BESST study).
Marie Jaïs et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it